Literature DB >> 6360367

Efficacy and safety of digital subtraction angiography with special reference to contrast agents.

W Seyferth, G Dilbat, E Zeitler.   

Abstract

We evaluated the diagnostic accuracy and complications of digital subtraction angiography (DSA) in a series of clinical trials conducted on patients primarily with cerebral vascular disease and those evaluated before and after surgery or percutaneous transluminal angioplasty. Double-blind studies of the carotid-vertebral arteries of 300 of the 2,200 patients using DSA imaging and a variety of ionic and nonionic contrast agents showed that although subjects tolerated the injection of nonionic contrast better than ionic, nonionic contrast administration did not lead to better image quality. Of 764 patients receiving ionic contrast media, 3.3% had mild-to-serve adverse reactions; of 350 injected with nonionic contrast agents, 1.7% had mild-to-severe adverse reactions. If the sole consideration is safety, use of ionic contrast media is justified.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360367     DOI: 10.1007/bf02552447

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  2 in total

1.  [Venous and arterial digitalised video subtraction angiography (DVSA). Initial experience with 120 examinations (author's transl)].

Authors:  W Seyferth; P Marhoff; E Zeitler
Journal:  Rofo       Date:  1982-03

2.  Experience with metrizamide in patients with previous severe anaphylactoid reactions to ionic contrast agents.

Authors:  S Rapoport; J J Bookstein; C B Higgins; P H Carey; M Sovak; E C Lasser
Journal:  Radiology       Date:  1982-05       Impact factor: 11.105

  2 in total
  2 in total

1.  Digital subtraction angiography (DSA) in neuroradiology.

Authors:  A L Agnoli
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

2.  Lowering iodinated contrast concentration in infrainguinal endovascular interventions: a three-armed randomized controlled non-inferiority trial.

Authors:  Sjoerd Jens; Sanne M Schreuder; Diederik W De Boo; Lukas C van Dijk; Hans van Overhagen; Shandra Bipat; Mark J W Koelemay; Jim A Reekers
Journal:  Eur Radiol       Date:  2015-12-02       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.